Noha Rayad, PhD

Director, Clinical Pharmacology and Safety Sciences
Alexion, AstraZeneca Rare Disease

Dr. Noha Rayad, PhD, has more than 20 years of experience in clinical drug development and different therapeutic modalities. She is a Director, Clinical Pharmacology & Safety Sciences at Alexion, AstraZeneca Rare Disease and an Associate Professor with proficient mentoring and teaching skills. Dr. Noha is leading the application of Clinical PK/PD, and Modeling & Simulation (MS) principles for informed drug development. She published >30 original research articles, reviews, white papers, tutorials and book chapters and presented her work at several conferences. Dr Noha conducted her PhD work at Uppsala University (Sweden) and a postdoc at Manchester University (UK). She has been an active member of ASCPT and involved in many activities and committees e.g. rare diseases, CGRN, network leadership and mentoring.

Presentation(s):

• Balancing Patient-Centric and Model-Informed Drug Development (MIDD) Approaches to Optimize Dose Selection in Rare Diseases: Are We There Yet?

  Thursday, May 29, 2025
  3:30 PM - 4:30 PM East Coast USA Time